Optimizing Drug Dosing in Diabetic Kidney Disease
Analysis Pharmacokinetics / TDM
Mousavi T, Shaya FT, Munir KM, et al.
Sep 8, 2026 · Published in: Expert Opinion on Drug Metabolism & Toxicology
Tailored dosing strategies are key in diabetic kidney disease drug therapy.
Two-Sample 3-and-7-Hour Schedule Optimizes Once-Daily Busulfan TDM
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Tan Z, Achini-Gutzwiller FR, Lankester AC, et al.
Sep 1, 2026 · Published in: Journal of Clinical Pharmacology
Enhance busulfan dosing with a precise two-sample strategy.
Bilirubin-Guided Voriconazole Dosing Improves Target Attainment in Liver Dysfunction
Analysis Pharmacokinetics / TDM Hypothesis-generating Grade: Low
Li J, Zhao Y, Liu H, et al.
Aug 27, 2026 · Published in: Frontiers in Pharmacology
Optimized voriconazole dosing enhances outcomes in liver dysfunction.
TDM Not Yet Justified for Non-Anti-TNF IBD Therapies
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Chater F, Butler TD, Limdi JK
Aug 19, 2026 · Published in: Frontiers in Gastroenterology (Lausanne, Switzerland)
Could TDM unlock better outcomes for advanced IBD therapies?
Pharmacist anti-MRSA time-outs cut use mainly in emergency departments
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Yamamoto R, Tagashira Y, An DD, et al.
Jul 11, 2026 · Published in: Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
Targeted pharmacist-led interventions reduce intensive care antibiotic use.
Nearly All ICU Vancomycin Patients Qualify for Missing TDM
Analysis Pharmacokinetics / TDM Hypothesis-generating Grade: Low
Ayhan YE, Sarı Küçük R, Özkan AN, et al.
Jul 7, 2026 · Published in: BMC Anesthesiology
Nearly all ICU patients on vancomycin need TDM monitoring.
AGNP 2026 Update Overhauls Therapeutic Drug Monitoring in Neuropsychopharmacology
Guideline Pharmacokinetics / TDM Practice-changing Grade: Low
Hart XM, Gründer G, Hiemke C, et al.
Jul 2, 2026 · Published in: Pharmacopsychiatry
Updated TDM guidelines refine neuropsychiatric drug dosing strategies.
Pooled 5-FU Population PK Model Supports Lean Mass and Model-Informed Dosing
Analysis Pharmacokinetics / TDM Hypothesis-generating Grade: Low
Briki M, Thoueille P, Joerger M, et al.
Jun 12, 2026 · Published in: Cancer Chemotherapy and Pharmacology
Leverage lean body mass for precise 5-FU dosing!